Subscribe By RSS or Email
Theralase Could Light Up Cancer Therapeutics

Theralase Could Light Up Cancer Therapeutics

Cancer patients don’t have many good treatment options. Once the disease is detected, most oncologists will surgically remove as much as possible and then use powerful radiation and chemotherapy to kill as many cells in those areas as possible. The side effects from these treatments can be terrible and patients are at a higher risk […]

Exosomes Shine a Light on Alzheimer’s Disease and CTE

Exosomes Shine a Light on Alzheimer’s Disease and CTE

Concussions are common in recreational and professional sports with an estimated 1.6 million sustained concussion-related injuries per year in the U.S. alone. Since concussions aren’t detectable using X-rays or CT scans, they often go undiagnosed and attempts to prevent them have been difficult. These concussions can lead to far more serious problems like chronic traumatic […]

Discovery Could Lead to Major Breakthrough in Alzheimer’s Disease and Other Brain Disorders

Discovery Could Lead to Major Breakthrough in Alzheimer’s Disease and Other Brain Disorders

Some leading scientists are making strides like never before in research for debilitating and deadly diseases, such as Alzheimer’s Disease (AD), Chronic Traumatic Encephalopathy (CTE) and Traumatic Brain Injury (TBI).  Currently, people afflicted with these conditions have little hope to avert disease progression and, sadly, death.  There is reason for optimism, though, with hundreds of […]

Recent Articles:

OxySure Systems Selected for USPTO / Smithsonian Innovation Expo

OxySure Systems Inc. (OTCQB: OXYS), developer of life-saving and easy-to-use emergency oxygen solutions leveraging its oxygen from powder technology, recently announced that it was selected by the United States Patent and Trademark Office (“USPTO”) to

Entia Enhances GROH® Reach with Starzz Distribution Agreement

Entia Biosciences Inc. (OTC: ERGO), an emerging leader in the field of nutrigenomics, recently announced a distribution agreement with Shooting Starzz LLC to represent its GROH® product line to over 24,000 salons across the US.

A New Cannabinoid-based Arthritis Therapy in the Making

Cannabinoids have been the focus of intense clinical research following the legalization of medical cannabis by several U.S. states. While pioneers like British-based GW Pharmaceuticals plc (NASDAQ: GWPH) have been actively studying cannabinoids since the 1990s, many

Premier Biomedical Adds Prominent Pathologist to Advisory Board

Premier Biomedical Inc. (OTC: BIEI), a research-based company that intends to discover and develop medical treatments for a wide range of diseases in humans, in collaboration with the University of Texas at El Paso and

Premier Biotechnology & Anti-CTLA4

Many forms of cancer are characterized by a lack of cellular apoptosis (e.g. cell death) and down-regulation of the immune system. In the case of the latter, cytotoxic T lymphocytes (“CTLs”) are largely responsible for

Entia Biosciences’ Supplements Could Prevent Dementia

Vitamin D deficiency has been associated with a number of conditions, ranging from cardiovascular disease to certain types of cancers, according to WebMD. On the other side of the coin, research suggests that vitamin D

Aethlon Medical (AEMD) CEO Note: A Novel Strategy To Address Ebola

Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. The current ebola outbreak in West Africa demonstrates the urgent need for therapeutic strategies to defend against

Premier Biomedical’s William Hartman Interviewed by Uptick Newswire

Premier Biomedical Inc. (OTC: BIEI), a biopharmaceutical company focused on developing and commercializing innovative treatment therapies for cancer, traumatic brain injury, Alzheimer’s disease, and other afflictions, was recently featured in a piece written by Uptick

The Federal Reserve Playing Analyst Damaging to Biotechnology Companies

The July 15 U.S. Federal Reserve report on monetary policy touched off a barrage of barely polite and not very muted commentary from one end of the web to the other this past week with

Premier Biomedical Gears Up for Two Important Clinical Trials

Premier Biomedical Inc. (OTC: BIEI), a biopharmaceutical company focused on developing and commercializing innovative therapies targeting cancer, traumatic brain injury, Alzheimer’s disease, MS and other serious conditions, recently announced that the William Beaumont Army Medical

Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic

Fat is driving the bus these days in one narrow, but widening, biotech sector as companies strive for dominance. Among these are Galectin Therapeutics Inc. (NASDAQ: GALT), Intercept Pharmaceuticals (NASDAQ: ICPT), Raptor Pharmaceuticals (NASDAQ: RPTP)

What RXi Pharmaceuticals’ Move to the Russell Microcap Index Means

RXi Pharmaceuticals Corp. (NASDAQ: RXII), a biotechnology company focused on discovering, developing, and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, recently began trading on the Russell Microcap index on June 27,